申请人:PFIZER INC
公开号:US20150322043A1
公开(公告)日:2015-11-12
The present invention relates to compounds of Formula I
and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, in particular as TrkA antagonists.
本发明涉及公式I化合物及其药学上可接受的盐,其中取代基如本文所述,并且它们在医学上的应用,特别是作为TrkA拮抗剂。